{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:09:09Z","timestamp":1785758949499,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.amjmed.2020.05.003","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T11:16:39Z","timestamp":1590750999000},"page":"e706-e715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention"],"prefix":"10.1016","volume":"133","author":[{"given":"Grant S.","family":"Lipman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Jurkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Burnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Marvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1347-0912","authenticated-orcid":false,"given":"Cassie","family":"Lowry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Navlyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik R.","family":"Swenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2020.05.003_bib0001","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/ham.2016.0077","article-title":"Medication use among Mount Everest climbers: practice and attitudes","volume":"17","author":"Luks","year":"2016","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156786","article-title":"Drug use on Mont Blanc: a study using automated urine collection","volume":"11","author":"Robach","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0003","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3357\/ASEM.4037.2014","article-title":"A retrospective study of acute mountain sickness on Mt. Kilimanjaro using trekking company data","volume":"85","author":"Eigenberger","year":"2014","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0004","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1152\/japplphysiol.01407.2006","article-title":"Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story","volume":"102","author":"Swenson","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/ham.2011.1084","article-title":"Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis","volume":"13","author":"Kayser","year":"2012","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2011.10.015","article-title":"Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review","volume":"59","author":"Seupaul","year":"2012","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0007","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1708-8305.2012.00629.x","article-title":"Acetazolamide for the prevention of acute mountain sickness\u2014a systematic review and meta-analysis","volume":"19","author":"Ritchie","year":"2012","journal-title":"J Travel Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0008","doi-asserted-by":"crossref","first-page":"e6779","DOI":"10.1136\/bmj.e6779","article-title":"Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis","volume":"345","author":"Low","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0009","article-title":"Interventions for preventing high altitude illness: part 1. Commonly-used classes of drugs","volume":"6","author":"Nieto Estrada","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.wem.2018.09.002","article-title":"Reduced acetazolamide dosing in countering altitude illness: a comparison of 62.5 vs 125 mg (the RADICAL Trial)","volume":"30","author":"McIntosh","year":"2019","journal-title":"Wilderness Environ Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0011","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.wem.2019.04.001","article-title":"In response to reduced acetazolamide dose for AMS by McIntosh et al","volume":"30","author":"Bennett","year":"2019","journal-title":"Wilderness Environ Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0012","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.wem.2017.07.005","article-title":"In response to ibuprofen vs acetaminophen in AMS prevention by Kanaan et al","volume":"28","author":"Lipman","year":"2017","journal-title":"Wilderness Environ Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0013","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1152\/japplphysiol.01572.2005","article-title":"Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness","volume":"102","author":"Leaf","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0014","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1152\/japplphysiol.00527.2004","article-title":"Early fluid retention and severe acute mountain sickness","volume":"98","author":"Loeppky","year":"2005","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF00643747","article-title":"Altitude diuresis: endocrine and renal responses to acute hypoxia of acclimatized and non-acclimatized subjects","volume":"62","author":"Koller","year":"1991","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0016","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/15270290260512846","article-title":"Hypoxic ventilatory response, ventilation, gas exchange, and fluid balance in acute mountain sickness","volume":"3","author":"Bartsch","year":"2002","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0017","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/ham.2008.1029","article-title":"Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness","volume":"9","author":"van Patot","year":"2008","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0018","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1503\/cmaj.091481","article-title":"Is bigger better? An argument for very low starting doses","volume":"183","author":"McCormack","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0019","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/bmj.321.7256.267","article-title":"Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review","volume":"321","author":"Dumont","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0020","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0002-9343(87)90937-5","article-title":"A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis","volume":"83","author":"Ellsworth","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0021","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/ham.2006.7.17","article-title":"Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial","volume":"7","author":"Basnyat","year":"2006","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0022","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/ham.2017.0164","article-title":"The 2018 Lake Louise Acute Mountain Sickness Score","volume":"19","author":"Roach","year":"2018","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0023","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.annemergmed.2012.01.019","article-title":"Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories","volume":"59","author":"Lipman","year":"2012","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0024","doi-asserted-by":"crossref","first-page":"200.e9","DOI":"10.1016\/j.amjmed.2017.05.034","article-title":"Budesonide versus acetazolamide for prevention of acute mountain sickness","volume":"131","author":"Lipman","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.amjmed.2018.10.021","article-title":"Altitude sickness prevention with ibuprofen relative to acetazolamide","volume":"132","author":"Burns","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0026","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/ham.2019.0007","article-title":"Day of ascent dosing of acetazolamide for prevention of acute mountain sickness","volume":"20","author":"Lipman","year":"2019","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0027","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/bja\/58.5.512","article-title":"Dissociation of renal and respiratory effects of acetazolamide in the critically ill","volume":"58","author":"Berthelsen","year":"1986","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0028","doi-asserted-by":"crossref","first-page":"e00203","DOI":"10.1002\/prp2.203","article-title":"Benzolamide improves oxygenation and reduces acute mountain sickness during a high-altitude trek and has fewer side effects than acetazolamide at sea level","volume":"4","author":"Collier","year":"2016","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0029","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-116-6-461","article-title":"Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange","volume":"116","author":"Grissom","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1580\/1080-6032(2004)015[0025:MAHATE]2.0.CO;2","article-title":"Medroxyprogesterone at high altitude. The effects on blood gases, cerebral regional oxygenation, and acute mountain sickness","volume":"15","author":"Wright","year":"2004","journal-title":"Wilderness Environ Med"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0031","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1152\/jappl.1995.78.2.377","article-title":"Diuretic effect of acute hypoxia in humans: relationship to hypoxic ventilatory responsiveness and renal hormones","volume":"78","author":"Swenson","year":"1995","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0032","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1183\/09031936.00185808","article-title":"No evidence for interstitial lung oedema by extensive pulmonary function testing at 4,559 m","volume":"35","author":"Dehnert","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0033","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/ham.2018.0143","article-title":"Physiological responses in humans acutely exposed to high altitude (3480 m): minute ventilation and oxygenation are predictive for the development of acute mountain sickness","volume":"20","author":"Burtscher","year":"2019","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0034","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1164\/ajrccm\/147.5.1239","article-title":"Operation Everest. II: spirometric and radiographic changes in acclimatized humans at simulated high altitudes","volume":"147","author":"Welsh","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1164\/ajrccm\/143.1.4","article-title":"Interpretation of the alveolar-arterial oxygen difference in patients with hypercapnia","volume":"143","author":"Gray","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0036","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/ham.2018.0123","article-title":"Interstitial pulmonary edema assessed by lung ultrasound on ascent to high altitude and slight association with acute mountain sickness: a prospective observational study","volume":"20","author":"Alsup","year":"2019","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0037","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/ehjci\/jev074","article-title":"Factors associated with B-lines after exposure to hypobaric hypoxia","volume":"16","author":"Strapazzon","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.amjmed.2020.05.003_bib0038","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/ham.2012.1084","article-title":"Acetazolamide for the prevention of acute mountain sickness: time to move on","volume":"14","author":"Penninga","year":"2013","journal-title":"High Alt Med Biol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320304393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320304393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:29:30Z","timestamp":1762079370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934320304393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0002934320304393"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.05.003","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}